Annual Secretarial Compliance Report for the financial year ended on March 31, 2026.
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences received its Annual Secretarial Compliance Report for FY 2025-26 from SPANJ & Associates. The report confirms the company largely complied with SEBI regulations covering LODR, ICDR, SAST, PIT, Depositories and other applicable regulations. One deviation was noted: the company provided only 1 working day's advance intimation (instead of the required 2 days) to stock exchanges for a board meeting on November 6, 2025 that considered a fund-raise proposal. The intimation was sent on November 3, 2025, but a public holiday on November 5 in Mumbai (while Ahmedabad was a working day) created a timing gap. BSE and NSE each imposed a fine of Rs. 11,800, which the company has paid. Management attributes this to a technical error. All other compliance checkpoints — secretarial standards, policies, website disclosures, board evaluations, related party transactions, and insider trading norms — were found satisfactory. No material non-compliances or actions pending from prior reports.
This is a routine annual compliance filing. The single deviation is minor and already settled with a small fine; it reflects a technical timing error rather than any substantive governance failure and is unlikely to materially impact investor sentiment or the stock price.